Tumor Biology

, Volume 37, Issue 8, pp 10763–10773 | Cite as

Transforming growth factor (TGF) β1 acted through miR-130b to increase integrin α5 to promote migration of colorectal cancer cells

  • Rui Yi
  • Yao Li
  • Feiliang Wang
  • Jianguo Gu
  • Tomoya Isaji
  • Jian Li
  • Ruomei Qi
  • Xiaoquan Zhu
  • Yanyang Zhao
Original Article


Transforming growth factor (TGF)-β1 is a significant stimulator of tumor invasion and metastasis. More recently, it has been found that TGF-β1 acts through microRNAs to regulate their target genes to promote cancer progresses. However, such similar regulation is rarely reported in colorectal cancer (CRC). Here, we observed a decrease in TGF-β1 expression in CRC specimens, compared with matched adjacent normal tissues. In parallel, there was an increase in miR-130b characterized in the same samples by microarray assay. Further, treatment of CRC cells with TGF-β1 caused a significant decrease in the expression of miR-130b and an increased CRC cell migration. Luciferase reporter assay revealed that miR-130b directly targeted the 3′ untranslated region (3′UTR) region of integrin α5 gene, which encodes a key molecule involved in cell motility. Subsequently, in the overexpression of miR-130b CRC cells, we observed a decreased level of integrin α5 protein. The regulation of integrin α5 by miR-130b was further shown using the miR-130b mimics and inhibitor of miR-130b. And, knockdown miR-130b with inhibitor in the overexpression of miR-130b CRC cells recovered integrin α5 expression and integrin α5-mediated cell motility. Moreover, the inverse relevance between miR-130b and integrin α5 was also observed in CRC specimens. At last, the enhancement of integrin α5 in TGF-β1-treated cells can be reversed partly when rescuing miR-130b expression. Together, our findings suggested that TGF-β1 acted through miR-130b to promote integrin α5 expression, resulting in the enhanced migration of CRC cells.


miR-130b TGF-β1 Cell motility Integrin 



This work was supported by National Natural Science Foundation of China Grant 81101859, National Natural Science Foundation of China Grant 81000780, National Natural Science Foundation of China Grant 81472408, National Natural Science Foundation of China Grant 81541152, and Beijing Natural Science Foundation 5102039.

Compliance with ethical standards

Conflicts of interest


Supplementary material

13277_2016_4965_Fig6_ESM.jpg (530 kb)
Supplementary Figure 1

Transwell migration assays of SW480 cells treated without or with 20 ng/mL TGF-β1 for 24 hours (scale bar=100 μm; mean±s.d.; n=3; *, P <0.05). Representative images of migrated cells were shown. (JPG 529 kb)

13277_2016_4965_Fig7_ESM.jpg (1.1 mb)
Supplementary Figure 2

The putative binding sites with the seed region of miR-130b were at 187-193bp (underlined) and 902-908bp (underlined) of the full-length integrin α5 3′UTR. (JPG 1117 kb)

13277_2016_4965_MOESM1_ESM.xlsx (43 kb)
Supplementary Table 1 The clinicopathologic features of 39 patients. (XLSX 42 kb)


  1. 1.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMedGoogle Scholar
  2. 2.
    Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3:453–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut. 2013;62:1315–26.CrossRefPubMedGoogle Scholar
  4. 4.
    Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology. 2006;131:830–40.CrossRefPubMedGoogle Scholar
  5. 5.
    Derynck R, Feng XH. TGF-beta receptor signaling. Biochim Biophys Acta. 1997;1333:F105–50.PubMedGoogle Scholar
  6. 6.
    Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science. 2002;296:1646–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Welch DR, Fabra A, Nakajima M. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci U S A. 1990;87:7678–82.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Akhurst RJ, Derynck R. TGF-beta signaling in cancer—a double-edged sword. Trends Cell Biol. 2001;11:S44–51.PubMedGoogle Scholar
  9. 9.
    Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 2001;29:117–29.CrossRefPubMedGoogle Scholar
  10. 10.
    Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, et al. High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology. 1996;110:375–82.CrossRefPubMedGoogle Scholar
  11. 11.
    Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11:252–63.CrossRefPubMedGoogle Scholar
  12. 12.
    Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6:590–610.CrossRefPubMedGoogle Scholar
  14. 14.
    Wang W, Peng B, Wang D, Ma X, Jiang D, Zhao J, et al. Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets. Int J Cancer. 2011;129:1624–34.CrossRefPubMedGoogle Scholar
  15. 15.
    Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL, et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature. 2010;467:986–90.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, et al. Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene. 2013;32:3286–95.CrossRefPubMedGoogle Scholar
  17. 17.
    Castro NE, Kato M, Park JT, Natarajan R. Transforming growth factor beta1 (TGF-beta1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells. J Biol Chem. 2014;289:29001–13.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Liu F, Kong X, Lv L, Gao J. TGF-beta1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes. Cancer Lett. 2015;359:288–98.CrossRefPubMedGoogle Scholar
  19. 19.
    Sun MM, Li JF, Guo LL, Xiao HT, Dong L, Wang F, et al. TGF-beta1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma. Oncogene. 2014;33:2075–86.CrossRefPubMedGoogle Scholar
  20. 20.
    Zhou H, Wang K, Hu Z, Wen J. TGF-beta1 alters microRNA profile in human gastric cancer cells. Chin J Cancer Res. 2013;25:102–11.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Zhao Y, Miao G, Li Y, Isaji T, Gu J, Li J, et al. MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin beta1 [corrected]. PLoS One. 2014;9, e87938.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673–87.CrossRefPubMedGoogle Scholar
  23. 23.
    Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol. 1996;8:724–30.CrossRefPubMedGoogle Scholar
  24. 24.
    Isaji T, Sato Y, Zhao Y, Miyoshi E, Wada Y, Taniguchi N, et al. N-glycosylation of the beta-propeller domain of the integrin alpha5 subunit is essential for alpha5beta1 heterodimerization, expression on the cell surface, and its biological function. J Biol Chem. 2006;281:33258–67.CrossRefPubMedGoogle Scholar
  25. 25.
    Kim BH, Hong SW, Kim A, Choi SH, Yoon SO. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol. 2013;107:505–10.CrossRefPubMedGoogle Scholar
  26. 26.
    Lai KW, Koh KX, Loh M, Tada K, Subramaniam MM, Lim XY, et al. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer. 2010;46:1456–63.CrossRefPubMedGoogle Scholar
  27. 27.
    Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, et al. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell Tissue Res. 2013;351:85–98.CrossRefPubMedGoogle Scholar
  28. 28.
    Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, Wang C, et al. Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol. 2012;48:686–91.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Muller SC, Ellinger J, et al. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World J Urol. 2014;32:353–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Bu P, Wang L, Chen KY, Rakhilin N, Sun J, Closa A, et al. miR-1269 promotes metastasis and forms a positive feedback loop with TGF-beta. Nat Commun. 2015;6:6879.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Li S, Fu H, Wang Y, Tie Y, Xing R, Zhu J, et al. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology. 2009;49:1194–202.CrossRefPubMedGoogle Scholar
  32. 32.
    Cai T, Lei QY, Wang LY, Zha XL. TGF-beta 1 modulated the expression of alpha 5 beta 1 integrin and integrin-mediated signaling in human hepatocarcinoma cells. Biochem Biophys Res Commun. 2000;274:519–25.CrossRefPubMedGoogle Scholar
  33. 33.
    Fong YC, Hsu SF, Wu CL, Li TM, Kao ST, Tsai FJ, et al. Transforming growth factor-beta1 increases cell migration and beta1 integrin up-regulation in human lung cancer cells. Lung Cancer. 2009;64:13–21.CrossRefPubMedGoogle Scholar
  34. 34.
    Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O, et al. Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin. Am J Pathol. 2002;161:183–93.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Katabami K, Mizuno H, Sano R, Saito Y, Ogura M, Itoh S, et al. Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region. Clin Exp Metastasis. 2005;22:539–48.CrossRefPubMedGoogle Scholar
  36. 36.
    Margadant C, Sonnenberg A. Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 2010;11:97–105.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Fransvea E, Angelotti U, Antonaci S, Giannelli G. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology. 2008;47:1557–66.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  • Rui Yi
    • 1
    • 2
  • Yao Li
    • 3
  • Feiliang Wang
    • 2
    • 3
  • Jianguo Gu
    • 4
  • Tomoya Isaji
    • 4
  • Jian Li
    • 2
  • Ruomei Qi
    • 2
  • Xiaoquan Zhu
    • 2
  • Yanyang Zhao
    • 1
    • 2
  1. 1.Peking University Fifth School of Clinical MedicineBeijing HospitalBeijingChina
  2. 2.The Key Laboratory of GeriatricsBeijing Hospital and Beijing Institute of Geriatrics, Ministry of HealthBeijingChina
  3. 3.Department of SurgeryBeijing HospitalBeijingChina
  4. 4.Division of Regulatory Glycobiology, Institute of Molecular Biomembrane and GlycobiologyTohoku Pharmaceutical UniversitySendaiJapan

Personalised recommendations